Upgrade to SI Premium - Free Trial

Indivior (INDV)

35.00 +0.21 (0.60%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Indivior to Report Third Quarter 2026 Financial Results October 19, 2026 8:30 AM - StreetInsider Form 8-K Indivior Pharmaceuticals For: Oct 15 October 15, 2026 4:18 PM - SEC Filing Form 425 Indivior Pharmaceuticals Filed by: Indivior Pharmaceuticals, Inc. October 6, 2026 7:17 AM - SEC Filing Form 8-K Indivior Pharmaceuticals For: Oct 06 October 6, 2026 7:15 AM - SEC Filing Form SCHEDULE 13G Indivior Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC September 30, 2026 6:35 PM - SEC Filing Form 425 Indivior Pharmaceuticals Filed by: Indivior Pharmaceuticals, Inc. September 17, 2026 7:21 AM - SEC Filing Form 8-K Indivior Pharmaceuticals For: Sep 16 September 17, 2026 7:18 AM - SEC Filing Indivior (INDV) Declares $8.13 Special Dividend; 23.7% Yield September 17, 2026 7:03 AM - StreetInsider Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend September 17, 2026 7:00 AM - StreetInsider Form 8-K Indivior Pharmaceuticals For: Sep 09 September 15, 2026 4:28 PM - SEC Filing Form EFFECT Indivior Pharmaceuticals September 14, 2026 6:03 AM - SEC Filing Form 424B3 Indivior Pharmaceuticals September 11, 2026 4:18 PM - SEC Filing Form S-4 Indivior Pharmaceuticals August 28, 2026 4:56 PM - SEC Filing Form 4 Indivior Pharmaceuticals For: Aug 27 Filed by: Anderson Woodrow D August 27, 2026 4:01 PM - SEC Filing Form SCHEDULE 13D/A Indivior Pharmaceuticals Filed by: Oaktree Capital Holdings, LLC August 13, 2026 5:31 PM - SEC Filing Form 4 Indivior Pharmaceuticals For: Aug 05 Filed by: Anderson Woodrow D August 5, 2026 4:52 PM - SEC Filing Indivior (INDV) PT Lowered to $43 at Barclays August 5, 2026 4:28 AM - StreetInsider Form 10-Q Indivior Pharmaceuticals For: Jun 30 August 3, 2026 4:25 PM - SEC Filing Form 425 Indivior Pharmaceuticals Filed by: Indivior Pharmaceuticals, Inc. August 3, 2026 8:34 AM - SEC Filing Form 8-K Indivior Pharmaceuticals For: Aug 03 August 3, 2026 8:33 AM - SEC Filing Indivior PLC (INDV) Tops Q2 EPS by 41c ; Offers Guidance August 3, 2026 7:07 AM - StreetInsider Form 425 Indivior Pharmaceuticals Filed by: Indivior Pharmaceuticals, Inc. August 3, 2026 6:53 AM - SEC Filing Form 8-K Indivior Pharmaceuticals For: Aug 03 August 3, 2026 6:50 AM - SEC Filing Form 425 Indivior Pharmaceuticals Filed by: Indivior Pharmaceuticals, Inc. August 3, 2026 6:43 AM - SEC Filing Form 8-K Indivior Pharmaceuticals For: Aug 01 August 3, 2026 6:41 AM - SEC Filing Supernus and Indivior agree to all-stock merger of equals August 3, 2026 6:31 AM - StreetInsider Indivior Reports Second Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance August 3, 2026 6:31 AM - StreetInsider Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale August 3, 2026 6:30 AM - StreetInsider Full Article List